This inventor holds 1 USPTO granted patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations of Wonhwa Lee in Pharmaceutical Composition
Introduction
Wonhwa Lee is an accomplished inventor based in Gyeongsangnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address vascular inflammation-related infectious diseases.
Latest Patents
Wonhwa Lee holds a patent for "2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof." This patent describes a pharmaceutical composition that includes a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative as an active ingredient. The composition is effective against vascular inflammation-related infectious diseases triggered by the activity of the HMGB1 protein. His research indicates that this pharmaceutical composition can enhance the survival rate in sepsis, as demonstrated through a CLP-induced sepsis animal test.
Career Highlights
Wonhwa Lee is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work focuses on innovative solutions in the pharmaceutical industry, particularly in developing therapeutic agents for serious health conditions.
Collaborations
He has collaborated with notable colleagues, including Jong-Sup Bae and Kyung-Sik Song, to advance research in his field.
Conclusion
Wonhwa Lee's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for critical health issues. His work continues to pave the way for advancements in medical science.